These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 23582365

  • 1. Pyrrolidine dithiocarbamate attenuates the development of monocrotaline-induced pulmonary arterial hypertension.
    Yavuz T, Uzun O, Macit A, Comunoglu C, Yavuz O, Silan C, Yuksel H, Yildirim HA.
    Pathol Res Pract; 2013 May; 209(5):302-8. PubMed ID: 23582365
    [Abstract] [Full Text] [Related]

  • 2. Pyrrolidine dithiocarbamate restores endothelial cell membrane integrity and attenuates monocrotaline-induced pulmonary artery hypertension.
    Huang J, Kaminski PM, Edwards JG, Yeh A, Wolin MS, Frishman WH, Gewitz MH, Mathew R.
    Am J Physiol Lung Cell Mol Physiol; 2008 Jun; 294(6):L1250-9. PubMed ID: 18390833
    [Abstract] [Full Text] [Related]

  • 3. Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats.
    Shi R, Wei Z, Zhu D, Fu N, Wang C, Yin S, Liang Y, Xing J, Wang X, Wang Y.
    Pulm Pharmacol Ther; 2018 Feb; 48():124-135. PubMed ID: 29133079
    [Abstract] [Full Text] [Related]

  • 4. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
    Mawatari E, Hongo M, Sakai A, Terasawa F, Takahashi M, Yazaki Y, Kinoshita O, Ikeda U.
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214
    [Abstract] [Full Text] [Related]

  • 5. A nuclear factor-kappaB inhibitor pyrrolidine dithiocarbamate ameliorates pulmonary hypertension in rats.
    Sawada H, Mitani Y, Maruyama J, Jiang BH, Ikeyama Y, Dida FA, Yamamoto H, Imanaka-Yoshida K, Shimpo H, Mizoguchi A, Maruyama K, Komada Y.
    Chest; 2007 Oct; 132(4):1265-74. PubMed ID: 17934115
    [Abstract] [Full Text] [Related]

  • 6. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
    Homma N, Morio Y, Takahashi H, Yamamoto A, Suzuki T, Sato K, Muramatsu M, Fukuchi Y.
    Respiration; 2006 Oct; 73(1):105-12. PubMed ID: 16432296
    [Abstract] [Full Text] [Related]

  • 7. Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.
    Jasmin JF, Mercier I, Dupuis J, Tanowitz HB, Lisanti MP.
    Circulation; 2006 Aug 29; 114(9):912-20. PubMed ID: 16940204
    [Abstract] [Full Text] [Related]

  • 8. Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin.
    Li XL, Guan RJ, Li JJ.
    J Cardiovasc Pharmacol; 2012 Aug 29; 60(2):219-26. PubMed ID: 22592772
    [Abstract] [Full Text] [Related]

  • 9. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
    Tofovic SP, Zhang X, Jackson EK, Dacic S, Petrusevska G.
    Vascul Pharmacol; 2006 Dec 29; 45(6):358-67. PubMed ID: 16872912
    [Abstract] [Full Text] [Related]

  • 10. Activation of AMPK prevents monocrotaline-induced pulmonary arterial hypertension by suppression of NF-κB-mediated autophagy activation.
    Zhai C, Shi W, Feng W, Zhu Y, Wang J, Li S, Yan X, Wang Q, Zhang Q, Chai L, Li C, Liu P, Li M.
    Life Sci; 2018 Sep 01; 208():87-95. PubMed ID: 30009823
    [Abstract] [Full Text] [Related]

  • 11. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
    Porvasnik SL, Germain S, Embury J, Gannon KS, Jacques V, Murray J, Byrne BJ, Shacham S, Al-Mousily F.
    J Pharmacol Exp Ther; 2010 Aug 01; 334(2):364-72. PubMed ID: 20430844
    [Abstract] [Full Text] [Related]

  • 12. [Effects of rosuvastatin on monocrotaline-induced pulmonary artery hypertension in rats].
    Li XL, Guan RJ, Xu QH, Wu ZY.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Mar 01; 39(3):247-53. PubMed ID: 21609531
    [Abstract] [Full Text] [Related]

  • 13. Rosuvastatin provides pleiotropic protection against pulmonary hypertension, right ventricular hypertrophy, and coronary endothelial dysfunction in rats.
    Sun X, Ku DD.
    Am J Physiol Heart Circ Physiol; 2008 Feb 01; 294(2):H801-9. PubMed ID: 18055512
    [Abstract] [Full Text] [Related]

  • 14. A urotensin II receptor antagonist, KR36676, decreases vascular remodeling and inflammation in experimental pulmonary hypertension.
    Lee JH, Park BK, Oh KS, Yi KY, Lim CJ, Seo HW, Lee BH.
    Int Immunopharmacol; 2016 Nov 01; 40():196-202. PubMed ID: 27611861
    [Abstract] [Full Text] [Related]

  • 15. Preventive treatment with atorvastatin ameliorates endothelial dysfunction of small pulmonary arteries in monocrotaline-induced pulmonary hypertensive rats.
    Lin Z, Jiang Z, Huang X, Cai X, Wang H, Xie L.
    Clin Exp Hypertens; 2017 Nov 01; 39(6):495-501. PubMed ID: 28628347
    [Abstract] [Full Text] [Related]

  • 16. Autologous transplantation of bone marrow-derived endothelial progenitor cells attenuates monocrotaline-induced pulmonary arterial hypertension in rats.
    Yip HK, Chang LT, Sun CK, Sheu JJ, Chiang CH, Youssef AA, Lee FY, Wu CJ, Fu M.
    Crit Care Med; 2008 Mar 01; 36(3):873-80. PubMed ID: 18431275
    [Abstract] [Full Text] [Related]

  • 17. Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats.
    Lu J, Shimpo H, Shimamoto A, Chong AJ, Hampton CR, Spring DJ, Yada M, Takao M, Onoda K, Yada I, Pohlman TH, Verrier ED.
    J Thorac Cardiovasc Surg; 2004 Dec 01; 128(6):850-9. PubMed ID: 15573069
    [Abstract] [Full Text] [Related]

  • 18. Role of nitric oxide and endothelin-1 in monocrotaline-induced pulmonary hypertension in rats.
    Mathew R, Zeballos GA, Tun H, Gewitz MH.
    Cardiovasc Res; 1995 Nov 01; 30(5):739-46. PubMed ID: 8595621
    [Abstract] [Full Text] [Related]

  • 19. [Influence of pyrrolidine dithiocarbamate (PDTC) on expression of transforming growth factor beta(1), matrix metalloproteinase-2 and tissue inhibitor-1 of metalloproteinase in rats with pulmonary damage induced by paraquat].
    Shao CF, Chang XL, Wu QE, Ban TT, Jiang N, Yao XM, Zhou ZJ.
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Oct 01; 26(10):577-82. PubMed ID: 19272247
    [Abstract] [Full Text] [Related]

  • 20. Aspirin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing the ERK/MAPK pathway.
    Gao H, Cheng Y, Zong L, Huang L, Qiao C, Li W, Gong B, Hu J, Liu H, Wang X, Zhao C.
    Clin Exp Hypertens; 2017 Oct 01; 39(1):34-41. PubMed ID: 28055284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.